Learn More
Medchemexpress LLC LSP-249 | 1801253-04-2 | 99.1% | 431.92 | 100 MG

Supplier: Medchemexpress LLC HY126378100MG
LSP-249 is a plasma kallikrein inhibitor under study for angioedema. It is extracted from patent WO2016011209A1 and has an EC50 less than 100 nM in cell. This product is for research use only and not sold to patients.
- Plasma kallikrein inhibitor
- EC50: < 100 nM (kallikrein in cell)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.